Refine by
Wound Care Solution Articles & Analysis
14 news found
” “With 36 million people worldwide currently suffering from chronic wounds, we urgently need novel solutions for hard-to-treat wounds,” said Valerio Maria Ferrari, Bioseutica Group Chairman and Co-Founder of Healiva®. ...
Microbion Corporation of Bozeman, MT, today announced that it has received non-dilutive funding through its strategic partnership with CUBRC, Inc., a Buffalo-based, independent not-for-profit research company, of up to $2.1 million from the US Navy through the Medical Technology Enterprise Consortium (MTEC) partnership. The funding project is titled “Pravibismane Suspension as a Topical, ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
(SNWV) focuses on the development and commercialization of innovative advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications of shockwave and ultrasound systems in the non-medical field, announced today the patent activity for the past year. ...
Cuts and lacerations are among the most common complaints that bring patients to urgent care clinics. Whether a wound originates from an accident with a sharp object, such as a kitchen knife or yard tool, or from a blunt force such as a fall, there may be a risk of infection. Urgent care providers are responsible for providing treatment that promotes healing and helps prevent wound infection. ...
microMend is an exciting new technology that reduces patient wait time while also providing the highest level of care. microMend is a wound closure device that shaped like a butterfly bandage and applied easily. ...
However, traditional wound care methods have several drawbacks, including cost, time, and patient limitations. ...
Improving dermatology patients’ experience during dermatology procedures means more than simply providing top-notch aesthetic treatment. It requires thoughtful interactions that address every aspect of the patient's visit including their physical comfort, emotional state, and socioeconomic status. Patients increasingly choose healthcare providers who can respond to their specific needs. ...
The medical field uses advanced technology in all facets of daily operations. Patient intake forms, record keeping, communication portals, invoicing, and of course, procedures are enhanced by technological advances. Those advances are now shaping dermatology wound care too. Besides improved patient experience and clinical outcomes, technological advances can also positively affect a ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field today presented results from a clinical case series that demonstrated improved wound healing when treated with its FDA-cleared, ...
(OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound ...
August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. The vascular closure device consists of an insertion sheath, dilator and an implant contained in a delivery system. It uses a patch placed against the artery wall ...
(OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra's advanced wound care products. Clyra Medical Technologies holds the exclusive ...
Rhodes will work closely with BioLargo and its recently formed medical subsidiary to commercialize its technology in the wound management and medical device markets. "I believe that the BioLargo technology presents a unique and cost-effective solution for a number of big problems facing the industry," stated Rhodes. ...